The report was uncontrolled, unblinded, not randomized, had no comparator arm, used patient-reported outcomes rather than validated pain instruments, and did not publish dose, effect size, confidence intervals, p-values, or systematically collected adverse events limitations that severely constrain any clinical inference
Body Pharm's advantage is transparency: a confirmed pre-filled pen, a stated 16 mg + 16 mg split, and a full published HPLC Certificate of Analysis where Alluvi's format, split, and COA are not shown at the Synedica point of sale
doi:10.1016/j.urology.2013.08.039
[DOI] [PMC free article] [PubMed] [Google Scholar] 61.Holmes R Comparative studies of adipose triglyceride lipase genes and proteins: an ancient gene in vertebrate evolution
For research built around the core three mechanisms, the GLOW blend is the established, convenient single-vial formulation